Sihvola M, Hurme M
Immunology. 1984 Feb;51(2):313-8.
Proliferative T cell responses against syngeneic (SMLC) and allogeneic (alloMLC) non-T cells were investigated during the splenic regeneration after an injection of a sublethal dose (300 mg/kg) of cyclophosphamide (Cy). Two days after Cy injection spleen contained no cells capable of proliferative responses. T cells from the regenerating spleens (on day 6-8) had a defective proliferative capacity: the reactivity in the SMLC was at the normal level while alloreactivity was negative. The alloMLC appeared by 14 days after Cy injection, and it was still lower than the alloMLC of the normal splenic T cells. Responding cells of the SMLC in the regenerating phase belonged to the Ly-1+2- cell population: anti-Ly-1 antibody + complement (C) diminished the SMLC by 80%, anti-Ly-2 antibody + C had no effect on the responsiveness of the regenerating T cells. The stimulation of this SMLC was less dependent on splenic adherent cells than the normal SMLC. The significance of these data to the origin of alloreactivity and to the role of the SMLC in the cytotoxic T cell responses are discussed.
在注射亚致死剂量(300mg/kg)环磷酰胺(Cy)后脾脏再生过程中,研究了针对同基因(SMLC)和异基因(alloMLC)非T细胞的增殖性T细胞反应。注射Cy后两天,脾脏中没有能够产生增殖反应的细胞。再生脾脏(第6 - 8天)中的T细胞增殖能力存在缺陷:SMLC中的反应性处于正常水平而异基因反应性为阴性。Cy注射后14天出现alloMLC,且仍低于正常脾脏T细胞的alloMLC。再生期SMLC的反应细胞属于Ly-1+2-细胞群体:抗Ly-1抗体 + 补体(C)使SMLC降低80%,抗Ly-2抗体 + C对再生T细胞的反应性无影响。与正常SMLC相比,这种SMLC的刺激对脾脏黏附细胞的依赖性较小。讨论了这些数据对异基因反应性起源以及SMLC在细胞毒性T细胞反应中的作用的意义。